NCT07369765 (DCB-CTO) is a NA clinical trial of Drug-Eluting Stent Group in Coronary Artery Disease, sponsored by Biruni University.

Who is sponsoring NCT07369765?

NCT07369765 is sponsored by Biruni University.

What drugs are being tested in NCT07369765?

Interventions in NCT07369765: Drug-Eluting Stent Group, Drug Coated Balloon Group.

What condition does NCT07369765 study?

NCT07369765 studies Coronary Artery Disease.

Is NCT07369765 still recruiting?

NCT07369765 is currently recruiting now. Last updated 27 January 2026.

Last reviewed 2026-01-27 · How we verify

NCT07369765: DCB-CTO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Drug-Coated Balloon Versus Drug-eluting Stent Angioplasty for Treatment of Chronic Total Occlusion - The DCB-CTO Trial

Recruiting now NA Last updated 27 January 2026

What this trial tests

NA trial testing Drug-Eluting Stent Group in Coronary Artery Disease in 200 participants. Currently enrolling.

Timeline

28 August 2025

Primary endpoint
1 August 2026

1 August 2027

Quick facts

Lead sponsor	Biruni University
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	200
Start date	28 August 2025
Primary completion	1 August 2026
Estimated completion	1 August 2027
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Drug-Eluting Stent Group
Drug Coated Balloon Group

Conditions studied

Coronary Artery Disease — all drugs for Coronary Artery Disease →

Sponsor

Biruni University

Who can join

Eligibility, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Chronic total occlusion (CTO) remains one of the most challenging lesions in coronary artery disease management. Percutaneous coronary intervention using drug-eluting stents is currently a standard treatment approach; however, drug-coated balloon angioplasty has emerged as a potential alternative strategy. This study aims to compare the clinical and angiographic outcomes of drug-coated balloon angioplasty versus drug-eluting stent implantation in patients undergoing percutaneous coronary intervention for chronic total occlusion. The study will include adult patients diagnosed with CTO who meet the predefined eligibility criteria. Outcomes related to procedural success and follow-up results will be evaluated to assess the effectiveness of both treatment strategies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Other Biruni University trials

Trials by the same sponsor.

NCT07509762 — Exercise Programs in Women With PCOS · NA · not yet recruiting
NCT07499843 — Synchronous vs. Asynchronous Telerehabilitation for High-Risk Infants · NA · not yet recruiting
NCT07495540 — Comparison of the Effects of Free Weight and Machine-Based Exercises on Muscular Parameters · NA · not yet recruiting
NCT07452328 — Postural Stability and Trunk Strength in Wrestlers · not yet recruiting
NCT07467525 — Neuromuscular Effects of Acute Fatigue in Adolescent Basketball · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07369765 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Biruni University
Last refreshed: 27 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07369765.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing